154 related articles for article (PubMed ID: 32449271)
41. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
[TBL] [Abstract][Full Text] [Related]
42. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.
El Nebrisi E; Javed H; Ojha SK; Oz M; Shehab S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023066
[TBL] [Abstract][Full Text] [Related]
43. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
[TBL] [Abstract][Full Text] [Related]
44. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models.
Hu LF; Lu M; Tiong CX; Dawe GS; Hu G; Bian JS
Aging Cell; 2010 Apr; 9(2):135-46. PubMed ID: 20041858
[TBL] [Abstract][Full Text] [Related]
45. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
[TBL] [Abstract][Full Text] [Related]
46. 1α,25-Dihydroxyvitamin D3 (VD3) Shows a Neuroprotective Action Against Rotenone Toxicity on PC12 Cells: An In Vitro Model of Parkinson's Disease.
de Siqueira EA; Magalhães EP; de Assis ALC; Sampaio TL; Lima DB; Marinho MM; Martins AMC; de Andrade GM; de Barros Viana GS
Neurochem Res; 2023 Jan; 48(1):250-262. PubMed ID: 36066698
[TBL] [Abstract][Full Text] [Related]
47. Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson's Disease.
Ardah MT; Bharathan G; Kitada T; Haque ME
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33172035
[TBL] [Abstract][Full Text] [Related]
48. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine.
Sarkar S; Gough B; Raymick J; Beaudoin MA; Ali SF; Virmani A; Binienda ZK
Neurosci Lett; 2015 Oct; 606():53-9. PubMed ID: 26321151
[TBL] [Abstract][Full Text] [Related]
49. Focused ultrasound enhanced intranasal delivery of brain derived neurotrophic factor produces neurorestorative effects in a Parkinson's disease mouse model.
Ji R; Smith M; Niimi Y; Karakatsani ME; Murillo MF; Jackson-Lewis V; Przedborski S; Konofagou EE
Sci Rep; 2019 Dec; 9(1):19402. PubMed ID: 31852909
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson's disease.
Thakur P; Nehru B
Mol Neurobiol; 2015 Feb; 51(1):209-19. PubMed ID: 24946750
[TBL] [Abstract][Full Text] [Related]
51. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
[TBL] [Abstract][Full Text] [Related]
52. Thymoquinone exerts neuroprotective effect in animal model of Parkinson's disease.
Ebrahimi SS; Oryan S; Izadpanah E; Hassanzadeh K
Toxicol Lett; 2017 Jul; 276():108-114. PubMed ID: 28526446
[TBL] [Abstract][Full Text] [Related]
53. The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson's Disease.
Thomas Broome S; Castorina A
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163768
[TBL] [Abstract][Full Text] [Related]
54. Amelioration of motor and non-motor deficits and increased striatal APoE levels highlight the beneficial role of pistachio supplementation in rotenone-induced rat model of PD.
Haider S; Madiha S; Batool Z
Metab Brain Dis; 2020 Oct; 35(7):1189-1200. PubMed ID: 32529399
[TBL] [Abstract][Full Text] [Related]
55. Prophylactic neuroprotective propensity of Crocin, a carotenoid against rotenone induced neurotoxicity in mice: behavioural and biochemical evidence.
Rao SV; Hemalatha P; Yetish S; Muralidhara M; Rajini PS
Metab Brain Dis; 2019 Oct; 34(5):1341-1353. PubMed ID: 31214956
[TBL] [Abstract][Full Text] [Related]
56. Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway.
Huang TT; Hao DL; Wu BN; Mao LL; Zhang J
Biochem Biophys Res Commun; 2017 Dec; 493(4):1443-1449. PubMed ID: 28986252
[TBL] [Abstract][Full Text] [Related]
57. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
58. Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.
Avcı B; Günaydın C; Güvenç T; Yavuz CK; Kuruca N; Bilge SS
Neurochem Res; 2021 Mar; 46(3):513-522. PubMed ID: 33247801
[TBL] [Abstract][Full Text] [Related]
59. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
[TBL] [Abstract][Full Text] [Related]
60. Benefits of p-coumaric acid in mice with rotenone-induced neurodegeneration.
Dolrahman N; Mukkhaphrom W; Sutirek J; Thong-Asa W
Metab Brain Dis; 2023 Jan; 38(1):373-382. PubMed ID: 36308586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
